Asociación Española de Farmacéuticos Católicos | Adverse Consequences of Rushing a SARS-CoV-2
16945
post-template-default,single,single-post,postid-16945,single-format-standard,cookies-not-set,vcwb,ajax_fade,page_not_loaded,,qode-theme-ver-16.6,qode-theme-bridge,wpb-js-composer js-comp-ver-6.0.5,vc_responsive

Adverse Consequences of Rushing a SARS-CoV-2

Adverse Consequences of Rushing a SARS-CoV-2

Vaccine Implications for Public Trust

Brit Trogen, MD, MS1; David Oshinsky, PhD1; Arthur Caplan, PhD1

JAMA. 2020;323(24):2460-2461. doi:10.1001/jama.2020.8917

As the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pandemic persists across the US and the world, the spotlight on vaccine science has never been more intense. Researchers across the globe are working rapidly to produce a potential vaccine, and 7 candidates are already in clinical trials.1 Operation Warp Speed, the vaccine development project announced by President Trump, has advocated for a vaccine to be made available in the US by the beginning of 2021.1 But for scientists and physicians, the term “warp speed” should trigger concern. Good science requires rigor, discipline, and deliberate caution. Any medical therapy approved for public use in the absence of extensive safeguards has the potential to cause harm, not only for COVID-19 prevention efforts and vaccine recipients, but also for public trust in vaccination efforts worldwide. CLICK TO READ MORE